XRAY
DENTSPLY·NASDAQ
--
--(--)
--
--(--)
XRAY fundamentals
DENTSPLY (XRAY) released its earnings on Feb 26, 2026: revenue was 961.00M (YoY +6.19%), beat estimates; EPS was 0.27 (YoY +3.85%), missed estimates.
Revenue / YoY
961.00M
+6.19%
EPS / YoY
0.27
+3.85%
Report date
Feb 26, 2026
XRAY Earnings Call Summary for Q4,2025
- Revenue Growth: Q4 2025 at $661M (+6.2% YoY), 2026 guidance of $3.5-3.6B reflects operational challenges but sets stage for 2H26 recovery.
- Profitability: 2025 Adjusted EPS $1.60, 2026 target $1.40-1.50 with $120M annual savings from restructuring.
- Strategic Shifts: Dividend elimination to free $128M/year, $120M annual reinvestment in growth initiatives.
- U.S. Focus: Dealer channel expansion, +50% clinical education, and R&D acceleration to drive implants and ortho recovery.
- Risks: $30M dealer inventory headwind in 2026, tariff impacts ($15M/Q4), and China BBP uncertainty.
EPS
Actual | 0.43 | -0.18 | 0.67 | 0.87 | 0.72 | 0.71 | 0.68 | 0.76 | 0.52 | 0.6 | 0.41 | 0.46 | 0.39 | 0.51 | 0.49 | 0.44 | 0.42 | 0.49 | 0.5 | 0.26 | 0.43 | 0.52 | 0.37 | 0.27 | |||||||||||||||
Forecast | 0.3892 | -0.0246 | 0.3166 | 0.6414 | 0.5697 | 0.6645 | 0.6493 | 0.7879 | 0.5618 | 0.5483 | 0.5224 | 0.3254 | 0.3392 | 0.4319 | 0.4832 | 0.435 | 0.4182 | 0.4961 | 0.4741 | 0.4271 | 0.2961 | 0.5065 | 0.4478 | 0.2775 | |||||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +10.48% | -631.71% | +111.62% | +35.64% | +26.38% | +6.85% | +4.73% | -3.54% | -7.44% | +9.43% | -21.52% | +41.36% | +14.98% | +18.08% | +1.41% | +1.15% | +0.43% | -1.23% | +5.46% | -39.12% | +45.22% | +2.67% | -17.37% | -2.70% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 874.30M | 491.00M | 894.80M | 1.08B | 1.03B | 1.07B | 1.07B | 1.09B | 965.00M | 1.00B | 947.00M | 983.00M | 978.00M | 1.03B | 947.00M | 1.01B | 953.00M | 984.00M | 951.00M | 905.00M | 879.00M | 936.00M | 904.00M | 961.00M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 884.10M | 492.55M | 839.02M | 997.38M | 947.57M | 1.01B | 1.03B | 1.13B | 991.01M | 1.01B | 1.01B | 941.92M | 937.70M | 998.98M | 975.21M | 971.51M | 969.45M | 993.61M | 939.10M | 920.59M | 853.64M | 935.05M | 896.60M | 926.15M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.11% | -0.31% | +6.65% | +8.48% | +8.38% | +5.40% | +4.27% | -3.63% | -2.62% | -0.68% | -6.04% | +4.36% | +4.30% | +2.91% | -2.89% | +4.17% | -1.70% | -0.97% | +1.27% | -1.69% | +2.97% | +0.10% | +0.82% | +3.76% |
Earnings Call
You can ask Aime
What is DENTSPLY's latest dividend and current dividend yield?What factors drove the changes in DENTSPLY's revenue and profit?What guidance did DENTSPLY's management provide for the next earnings period?What were the key takeaways from DENTSPLY's earnings call?What is the revenue and EPS growth rate for DENTSPLY year over year?Did DENTSPLY beat or miss consensus estimates last quarter?What is the market's earnings forecast for DENTSPLY next quarter?What is DENTSPLY's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
